|

FZ-AD005 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.1

Indications

  • Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)1
  • Lung Cancer1
  • Cancer1

Other1 trial

A Study of FZ-AD005 in Patients With Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.